Search results - 162 results
Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening program.
Volume 28, Issue 1 (2019) Keywords: Adult Early Detection of Cancer Female France Humans middle aged morbidity Papillomavirus Vaccines REGISTRIES Uterine Cervical Neoplasms Abstract: In 1994, a pilot ...
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.
Volume 363 (2018) Keywords: Colposcopy Early Detection of Cancer Female Humans incidence Intention to Treat Analysis Mass Screening Papillomaviridae Papillomavirus Infections Randomized Controlled Trials ...
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.
Publication Type: Peer reviewed scientific article Authors: M. Arbyn; Lan Xu Source: Expert Rev Vaccines, Volume 17, Issue 12 (2018) Keywords: Cervical cancer; HPV vaccines; meta-analysis; ...
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
consistently showed excellent clinical performance and can be considered validated for primary cervical cancer screening. Health Topics: Quality of healthcare Cancer Qualité des soins de santé Kwaliteit van de ...
Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening.
Guidelines as Topic Reproducibility of Results Sensitivity and Specificity Uterine Cervical Neoplasms Abstract: BACKGROUND Cervical cancer screening with assays detecting DNA of high-risk human papillomavirus ...
VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples
C Cocuzza; F H Zhao; S Van Keer; A Vorsters Source: J Clin Virol, Volume 107 (2018) Keywords: cervical cancer diagnostic test accuracy SCREENING self-sampling Test validation Urine collection VALHUDES ...
Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.
Alphapapillomavirus Cervical Intraepithelial Neoplasia Cervix Uteri Diagnostic Tests, Routine DNA, Viral Early Detection of Cancer Female Genotyping Techniques Humans Papillomavirus Infections Uterine Cervical ...
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
causally linked with the development of cervical precancer and cancer. HPV types 16 and 18 cause approximately 70% of cervical cancers worldwide. OBJECTIVES: To evaluate the harms and protection of ...
Evaluation of the clinical performance of the HPV-Risk assay using the VALGENT-3 panel.
Abstract: Human papillomavirus (HPV) testing is being increasingly incorporated into cervical cancer screening. VALGENT (VAL idation of HPV GEN otyping Tests) is a framework designed to evaluate the clinical ...
Accuracy of combinations of visual inspection using acetic acid or lugol iodine to detect cervical precancer: a meta-analysis.
with acetic acid (VIA) or with Lugol’s iodine (VILI) have been evaluated for cervical cancer screening in developing countries. OBJECTIVES: To assess the diagnostic accuracy and clinical utility of ...